Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 235 (ZNF235) is a member of the Kruppel family of zinc finger proteins within the zinc finger protein superfamily[1]. It contains Kruppel-associated box (KRAB) A and B domains and 15 tandemly arrayed C2H2-type zinc finger domains, making it a prototypical C2H2-type DNA-binding transcription factor[1][3]. ZNF235 is thought to function in the transcriptional regulation of gene expression, though precise downstream genes and cellular roles remain incompletely characterized[1]. It is an ortholog of the mouse Zfp93 protein and is located in a cluster of zinc finger genes on human chromosome 19q13.2[1]. Diseases associated directly with ZNF235 include esophageal adenosquamous carcinoma and alexithymia[1]. There are no known therapeutic drugs targeting ZNF235 as of current available data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 235 (ZNF235).